Clinical trials

  • Lyophilized bacterial lysates of: Haemophilus influenzae, Streptococcus (Diplococcus) pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Moraxella (Branhamella/Neisseria) catarrhalis (OM-85) for Respiratory tract infections with wheezing lower respiratory illness
  • Zimberelimab for Non-small cell lung cancer
  • Enzalutamide for Prostate cancer | Localized high-risk prostate cancer
  • Axicabtagene ciloleucel for Relapsed/Refractory Follicular lymphoma
  • ENTR-601-44 for Duchenne muscular dystrophy
  • HUMAN IGG2 MONOCLONAL ANTIBODY AGAINST IL-6 for Thyroid eye disease
  • OLECLUMAB for Metastatic triple negative breast cancer
  • FAPI-46 (labelled with Gallium-68) for Advanced liver fibrosis | Hepatic fibrosis
  • Pembrolizumab for Non-small cell lung cancer
  • RITUXIMAB for Diffuse large B-cell lymphoma (ABC)
  • Edoxaban for Acute ischemic stroke
  • RILUZOLE for Spasticity | Spinal cord injury